RxDoctor Payments Data
★ My doctorsLook up a doctor →

Eric Orzeck

Endocrinology, Diabetes & Metabolism · Friendswood, TXNPI 1356342406

Payments from drug & device makers

$27,054in general payments, 2019–2025

Across 729 payments — averaging $37.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$5K
  • Amgen$4K
  • Lilly USA, LLC$2K
  • AstraZeneca$2K
  • Mannkind Corporation$1K
  • Sanofi-aventis U.S. LLC$1K
  • plus $12K from 54 others

What the payments were for

  • Consulting fees$4,58317%
  • Speaking & faculty fees$1801%
  • Travel & lodging$1581%
  • Food & beverage$22,04081%
  • Education$340%
  • Gifts$590%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk45$5,327
Amgen(2 entities)89$3,842
Lilly USA, LLC79$2,055
AstraZeneca(2 entities)43$1,876
Mannkind Corporation59$1,134
Sanofi-aventis U.S. LLC38$1,133
Amarin Pharma, Inc.30$863
Corcept Therapeutics26$724
AbbVie(2 entities)28$583
Madrigal Pharmaceuticals7$579
Esperion Therapeutics, Inc.16$536
Vertex1$533
Boehringer Ingelheim29$495
Cequr Corporation6$470
Tandem Diabetes Care, Inc.8$433
Medtronic(2 entities)14$422
Dexcom, Inc.15$386
Recordati_rare_diseases_inc.13$366
Xeris Pharmaceuticals, Inc.14$360
Abbott15$310
Bayer10$295
Daiichi Sankyo Inc.11$271
Ascensia Diabetes Care US Inc.3$269
BETA Bionics, Inc.6$268
Insulet Corporation13$238
Ascendis Pharma Endocrinology Inc4$236
Amneal Pharmaceuticals LLC14$221
Avvisto Therapeutics, LLC1$182
Kyowa Kirin, Inc.3$180
Intuity Medical Inc4$178
Novartis5$173
Takeda Pharmaceuticals U.S.A., Inc.3$171
Johnson & Johnson6$167
Sequel Med Tech, LLC2$146
Radius Health, Inc.6$133
Aytu Biopharma, Inc.4$131
Akcea Therapeutics, Inc.1$122
Shire North American Group Inc3$120
Neurocrine Biosciences, Inc.4$114
IBSA Pharma Inc.7$102
Verity Pharmaceuticals Inc.4$93
Mallinckrodt Enterprises LLC1$85
Ultragenyx Pharmaceutical Inc.4$83
Merck5$78
Amryt Pharma Holdings Ltd3$54
BD3$52
Zealand Pharma US, Inc.2$45
Scilex Pharmaceuticals Inc.1$42
Currax Pharmaceuticals LLC3$41
Nevro Corp.1$34
Antares Pharma, Inc.2$33
Gilead1$28
Kvk-tech, Inc.1$25
Curium US LLC1$22
EUSA Pharma (US) LLC1$21
Endo Pharmaceuticals Inc.1$19
Amphastar Pharmaceuticals, Inc.1$19
Ipsen Biopharmaceuticals, Inc1$18
Aegerion Pharmaceuticals, Inc.1$17
Eisai Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,054 in reported general payments places this provider in the 75th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.

See all endocrinology, diabetes & metabolism providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$60,569
TrulicityDulaglutide23$49,854
MounjaroTirzepatide29$40,213
JardianceEmpagliflozin26$36,722
FarxigaDapagliflozin Propanediol26$28,439
SynthroidLevothyroxine Sodium179$22,314
Tresiba Flextouch U-200Insulin Degludec16$14,061
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$11,919
InvokanaCanagliflozin18$10,082
Testosterone18$6,438
Testosterone Cypionate25$1,725
Levothyroxine Sodium78$1,508
Pioglitazone-MetforminPioglitazone Hcl/Metformin Hcl20$1,252
Rosuvastatin Calcium57$722
Pioglitazone Hcl32$497

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$2,055$90,06752 claims
Novo NordiskOzempic$5,327$60,56932 claims
Boehringer IngelheimJardiance$495$36,72226 claims
AstraZenecaFarxiga$1,876$28,43926 claims
AbbVieSynthroid$583$22,314179 claims
Johnson & JohnsonInvokana$167$10,08218 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid$221$1,96898 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.

Other endocrinology, diabetes & metabolism in Friendswood

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →